[6-K] Haleon plc American Current Report (Foreign Issuer)

Rhea-AI Filing Summary

Haleon plc reports the purchase and cancellation of 1,600,000 ordinary shares of £0.01 each as part of the second tranche of its buyback programme announced 31 July 2025. After settlement, registered share capital is 8,973,306,495 ordinary shares, with 3,880,205 held as treasury shares, leaving 8,969,426,290 voting ordinary shares. A full breakdown of individual trades is available via the provided RNS link and on the Company website. The announcement states it does not constitute an offer for securities.

Positive

• 1,600,000 shares purchased and cancelled under the second tranche of the buyback programme
• Updated registered share capital of 8,973,306,495 ordinary shares and voting shares total of 8,969,426,290
• Full breakdown of individual trades provided via RNS link and posted on the company website

Negative

• None.

Insights

Financial Analyst

TL;DR: Company executed a programme buyback tranche and updated its issued and voting share counts.

The filing confirms the purchase and cancellation of 1,600,000 ordinary shares under the second tranche of the previously announced buyback programme. The company provides updated share capital and voting share counts, and directs readers to a full trade breakdown via RNS and the company website. This is a routine disclosure that clarifies share capital after an announced repurchase activity.

Corporate Governance Expert

TL;DR: Disclosure meets regulatory requirements, supplying trade breakdown and updated share figures for shareholder notification rules.

The document cites compliance with the Market Abuse Regulation disclosure requirement by providing a link to the individual trade breakdown and explicitly states the voting share total that shareholders should use for notification thresholds. The announcement includes customary legal language that it is not an offer to sell securities.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of August 2025

Commission File Number: 001-41411

Haleon plc

(Translation of registrant’s name into English)

Building 5, First Floor, The Heights,

Weybridge, Surrey, KT13 0NY

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

EXHIBIT INDEX

Exhibit Number	Description
99.1	18 August 2025 - “Transaction in Own Shares”

99.1

Haleon plc: Transaction in own shares

18 August 2025: Haleon plc (the "Company" or "Haleon") today announces the purchase of 1,600,000 ordinary shares of £0.01 each in the Company (the "Shares") for cancellation under the second tranche of its share buyback programme announced on 31 July 2025.

	London Stock Exchange	CBOE (UK)/BXE	CBOE (UK)/CXE
Date of purchase:	15 August 2025	15 August 2025	15 August 2025
Number of Shares purchased:	1,600,000	-	-
Highest price paid per Share (p):	359.9000	-	-
Lowest price paid per Share (p):	354.9000	-	-
Volume weighted average price paid per Share (p):	357.1774	-	-

Following the settlement of the above, the Company's registered share capital is 8,973,306,495 ordinary shares of £0.01 each, of which 3,880,205 are held as treasury shares. Therefore, the number of ordinary shares with voting rights is 8,969,426,290 and this figure may be used by shareholders to determine if they are required to notify their interest, or a change to their interest, in Haleon under the FCA's Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), a full breakdown of the individual trades is available at the link below:

http://www.rns-pdf.londonstockexchange.com/rns/6088V_1-2025-8-15.pdf

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

This announcement and individual trade breakdown will also be available on the Company's website at: www.haleon.com/investors.

Enquiries
Investors		Media
Jo Russell	+44 7787 392441	Zoë Bird	+44 7736 746167
Rakesh Patel	+44 7552 484646	Victoria Durman	+44 7894 505730
Email: investor-relations@haleon.com		Email: corporate.media@haleon.com

About Haleon

Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.

For more information, please visit www.haleon.com. 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		HALEON PLC (Registrant)
Date: August 18, 2025	By:	/s/ Amanda Mellor
		Name:	Amanda Mellor
		Title:	Company Secretary

FAQ

What shares did Haleon (HLN) repurchase in this filing?

The Company repurchased and cancelled 1,600,000 ordinary shares of £0.01 each under the second tranche of its buyback programme.

How many voting shares does Haleon (HLN) have after this transaction?

After settlement the number of ordinary shares with voting rights is 8,969,426,290.

Where can I find the detailed breakdown of the individual trades?

A full breakdown is available at the RNS link provided in the announcement and on the Company website at www.haleon.com/investors.

Does this announcement constitute an offer for securities?

No. The announcement explicitly states it does not constitute, or form part of, an offer or solicitation for securities in any jurisdiction.

How many treasury shares does Haleon hold after the buyback?

The Company holds 3,880,205 treasury shares following settlement.